Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Favored Organic product for Seniors' Prosperity: Make Your Determination - 2Well informed: How to Take full advantage of Your Gadgets
- 3Striking American and European television Projects: A Survey
- 4Ocean side Locations for a Family Excursion
- 5Vote in favor of your Number one method for commending a birthday
- French rapper Gims placed under investigation for 'aggravated money laundering'
- Practice environmental safety in Style: Divulging Famous Electric Vehicle Brands
- 6 Useful Home Espresso Machines
- Minute Maid’s frozen juice concentrate is ending after 80 years — and so is a certain kind of kitchen ritual
- New law puts familiar drinks, creams and gummies in legal limbo
- Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It
- IDF kills four terrorists equipped with weapons, surveillance gear near Gaza's Yellow Line
- Inconceivable Spots To Stargaze All over The Planet
- The Century Coupe Could Be Toyota’s Most Ambitious Car Since the LFA
